Entera Bio initiated by Leerink with $9 target, Outperform rating
Leerink Partners initiated coverage on Entera Bio Ltd. (ENTX) with an ‘Outperform’ rating and a $9 price target. ENTX closed at $3.03 per share on September 17, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.